Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Mar 31;104(4):744–753. doi: 10.1097/TP.0000000000003060

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2019 The Author(s). Published by Wolters Kluwer Health, Inc.

This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

PMC Copyright notice

FIGURE 5. — The treatment effect of LP on the cellular infiltrate in the allograft. The influx of CD45⁺, CD3⁺, and F4/80⁺ cells after treatment was determined with FACS and calculated to cell count per whole kidney. CD45⁺ and F4/80⁺ infiltrates are reduced after treatment with LP compared with P and NA. CD3⁺ infiltrates are reduced after treatment with LP compared with NA treatment (mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.001, one-way analysis of variance with a Tukey multiple comparisons test. NA = no additional treatment; N = 6, P = Prednisolone, N = 6, LP = liposomal prednisolone, N = 6).